Description
Added on the 22/06/2020 07:56:31 - Copyright : AFP EN
Novo Progresso, Aug 18 (EFE).- A group of indigenous people on Tuesday held a protest blockading highway BR-163, an important road that crosses Brazil from north to south, against a lack of medical assistance for COVID-19, environmental concerns and the president's infrastructure plans for the Amazon.Members of the Kayapó ethnic group sat on the asphalt in Novo Progresso municipality in the Amazonian state of Pará, located in the north of Brazil, waiting to be heard by regional authorities.(Camera: ERNESTO CARRICO)FOOTAGE SHOWS A GROUP OF INDIGENEOUS PEOPLE PROTESTING IN THE BR-163 ROAD IN NOVO PROGRESSO, IN THE STATE OF PARÁ IN THE NORTH OF BRAZIL.
Quito, Jun 30 (EFE).-The situation in the Ecuadorian capital has reached such an extreme leve that even the city of Guayaquil, which three months ago became the epicenter of the coronavirus outbreak in Ecuador, has offered to send medical personnel to help support the COVID-19 battle in the capital.On Tuesday, 21 doctors from the Municipal Hospital Bicentennial of Guayaquil arrived in Quito to help in the improvised medical center of the same name located in the capital. Guayaquil will also help support the capital with 80,000 units of medicines, personal protective equipment and 2,000 PCR tests.As of Tuesday, Quito has registered 6,571 coronavirus infections and 460 deaths. (Camera: JUAN FRANCISCO CHÁVEZ).FOOTAGE SHOW THE ARRIVAL OF MEDICAL PERSONNEL FROM GUAYAQUIL IN QUITO, ECUADOR; B-ROLLS OF QUITO STREETS; AND DOCTORS TREATING COVID-19 PATIENTS AT IESS QUITO SUR HOSPITAL IN QUITO, ECUADOR.
Manaus (Brazil), Jan 28 (EFE).- (Camera: Raphael Alves) Ilton Alves has been fighting Covid-19 in the Amazon for more than ten days. He had to pay for the oxygen out of his pocket. Neither his private health insurance nor the public service has treated him. They are collapsed. It is the dramatic reality of the Brazilian state most affected by the pandemic.FOOTAGE OF ILTON AND HIS WIFE ADJANIR.SOUNDBITES AND TRANSLATION OF:Adjanir:"At 58 years old I never thought I would go through everything I'm going through. Seeing my husband sick, without a hospital to take care of him, without having an emergency care, if a life or death situation happens, I have nowhere to go and I have to work to pay the bills and at the expense of getting sick too." Ilton:"I never imagined that I would need oxygen at home, because we have health insurance. The last time I went to the hospital they didn't see me because the hospital was closed. The security guard said it was closed and there would be no service at all. I was sad because we paid health insurance and yet nothing happened at the time. There was no need to hospitalize, but at least to tend to patients, prescribe medications. I went home discouraged."
With the second-highest COVID-19 death toll in the world, Brazil is experiencing a huge surge in new cases. Nevertheless, Business Insider reports the country's president, Jair Bolsonaro, says he has no plans to take Pfizer-BioNTech's vaccine against the virus. Bolsonaro has already had COVID-19 and says he is now immune. He called those who criticize his refusal to be vaccinated 'idiots' and 'imbeciles. Thursday, Bolsonaro suggested that the vaccine could produce bizarre side-effects, such as women growing beards or men speaking in effeminate voices. In the Pfizer contract, it's very clear. 'We're not responsible for any side effects.' If you turn into a crocodile, that's your problem. Jair Bolsonaro President of Brazil
Researchers working to develop a vaccine against COVID-19 must consider a few things. The inevitable mutation of the virus is one of the most important considerations, says UPI. They must also monitor its evolution to ensure that inoculations continue to prevent infection. New vaccines could become available as early as later this year. Researchers should use virus samples collected during testing to check for new strains. New strains could mean that the virus may not respond to the vaccine formulation.
|
Support : Technical 
- Content 
- Editors 
